Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2026 17:15 ET | Source: Iovance Biotherapeutics, Inc.

Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma

SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel...
July 12, 2025 07:36 ET | Source: Bleichmar Fonti & Auld

IOVA FRAUD ALERT: Iovance Biotherapeutics 44% Stock Drop Triggers Securities Fraud Class Action – Investors Notified to Contact BFA Law by July 14 (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before the July 14, 2025 securities fraud class action deadline.
July 11, 2025 10:32 ET | Source: Faruqi & Faruqi LLP

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Iovance To Contact Him Directly To Discuss Their Options If you purchased or...
July 10, 2025 08:18 ET | Source: Bleichmar Fonti & Auld

IOVA COURT NOTICE: Iovance Biotherapeutics Investors may have been Affected by Fraud – Contact BFA Law by the July 14 Legal Deadline (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before the July 14, 2025 securities fraud class action deadline.
July 08, 2025 08:46 ET | Source: Bleichmar Fonti & Auld

IOVA NOTICE: Iovance Biotherapeutics Shareholders are Notified of the Pending Class Action Lawsuit -- Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before the July 14, 2025 securities fraud class action deadline.
July 06, 2025 08:10 ET | Source: Faruqi & Faruqi LLP

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their Options If...
July 06, 2025 07:46 ET | Source: Bleichmar Fonti & Auld

IOVA SHAREHOLDER ALERT: Suffer Losses on Iovance Biotherapeutics? Contact BFA Law by July 14 Securities Fraud Class Action Deadline (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before the July 14, 2025 securities fraud class action deadline.
July 04, 2025 08:08 ET | Source: Bleichmar Fonti & Auld

IOVA SHAREHOLDERS: The Iovance Biotherapeutics July 14 Class Action Deadline is Approaching -- Contact BFA Law if You Suffered Losses (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before the July 14, 2025 securities fraud class action deadline.
July 02, 2025 08:46 ET | Source: Bleichmar Fonti & Auld

IOVA CLASS ACTION: A Class Action was filed against Iovance Biotherapeutics for Securities Fraud -- Contact BFA Law by July 14 Legal Deadline (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before the July 14, 2025 securities fraud class action deadline.
June 30, 2025 08:34 ET | Source: Bleichmar Fonti & Auld

IOVA LAWSUIT DEADLINE: Suffer Losses on Iovance Biotherapeutics? Contact BFA Law before the July 14 Securities Fraud Class Action Deadline (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before the July 14, 2025 securities fraud class action deadline.